Where Jazz Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Jazz Pharmaceuticals (NASDAQ:JAZZ) within the last quarter, with an average price target of $209.86, implying an upside from the current price of $124.3. The average price target has increased by 3.51% from the previous average of $202.75.
July 11, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have provided bullish ratings for Jazz Pharmaceuticals, with an average price target of $209.86, implying an upside from the current price of $124.3.
The bullish ratings and increased price target from analysts suggest a positive outlook for Jazz Pharmaceuticals. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100